2ES-14643-94448
4 vaccinations
1 coded response
38 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
6MW-16158-00813
Child or adolescent in my care · Female · 2022-06-27
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-05
Dose 2 — Pfizer-BioNTech
-
2021-02-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-09
- 2021-08-08
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2022-02-05
-
2022-04-05
Dose 4 — Pfizer-BioNTech
-
2022-04-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-07
- 2022-04-08
- 2022-04-09
- 2022-04-10
- 2022-04-12
- 2022-04-19
- 2022-04-26
-
2022-05-03
Survey response — day 28, dose 4MedDRA: Cough, Dyspnoea, Fatigue, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, fatigue, runny nose, shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-05-10
- 2022-05-17
- 2022-07-05
- 2022-10-04
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-04-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-16 | priority 2/3 |
Free text
Release 11 — day 28, dose 4
Symptoms: Cough, fatigue, runny nose, shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release